Rapid health impact assessment of aspirin promotion for the secondary prophylaxis of vascular events in Wales

Quality in Primary Care

Volumn 20, Issue 4, 2012, Pages 299-301

  Morgan, Gareth ^a  

^a National Leadership Innovation Agency for Healthcare   (United Kingdom)

Author keywords

Aspirin; Prophylaxis; Vascular events; Wales

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

ARTICLE; HEALTH IMPACT ASSESSMENT; HEART INFARCTION; HUMAN; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED KINGDOM;

ANTICOAGULANTS; ASPIRIN; HEALTH IMPACT ASSESSMENT; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WALES;

EID: 84867565011     PISSN: 14791072     EISSN: 14791064     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Antithrombotic Triaiists' Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. The Lancet 2009;373: 1849-60.
2. Morgan G. Ethical aspects in relation to aspirin prophylaxis. Quality in Primary Care 2008:16(6):433-40.
3. Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT and Chiu PW. Continuation of low-dose aspirin therapy in peptic ulcer bleeding. A randomised trial. Annals of Internal Medicine 2010;152:1-9.
4. Elwood P, Hughes J, Morgan GP, Brown G and Longley M. A survey of aspirin prophylaxis in Wales. Quality in Primary Care 2005; 119:734-7.
5. Elwood P, Morgan G, White J et al. Aspirin taking in a south Wales county. British Journal of Cardiology 2011; 18:238-40.
6. Garcia Rodriguez LA, Cea-Soriano L, Martin-Merino E and Johansson S. Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ 2011;343:d4094 doi: 10.1136/ bmj.d4094
7. Zaninelli A, Kaufholz C and Schwappach D. Physicians' attitudes toward post-MI aspirin prophylaxis: findingsfrom an online questionnaire in Europe and Latin America. Postgraduate Medicine 2009;121:44-53.
8. Morgan G. A health impact assessment of increased aspirin use in Wales. Public Health 2005;119(8):734-7. (Pubitemid 40790504)
9. Kerse N, Buetow S, Mainous AG, Young G, Coster G and Arroll B. Physician-patient relationship and medication compliance: A primary care investigation. Annals of Family Medicine 2004;5(2):455-61. (Pubitemid 39421116)
10. Herret E, Smeeth L, Walker L and Weston C. The Myocardial Ischaemia National Audit Project (MINAP). Heart 2010;96:1264-7.